PURPOSE: To evaluate C-11 choline positron emission tomography/computed tomography (CholPET) in staging and determining patterns of recurrence in prostate cancer patients with rising prostate-specific antigen levels after prostatectomy radiation therapy (RT). METHODS AND MATERIALS: The study includes patients with biochemical failure after postprostatectomy RT who underwent CholPET between 2008 and 2015. Patient and disease characteristics were examined in relation to sites of recurrence. All RT dosimetry records were reviewed, and recurrences were mapped on a representative computed tomography dataset with their relationship relative to the irradiated fossa field as out of field (OOF), edge of field (EOF; recurrence within <45-Gy isodose lines), or in field (IF; recurrence within ≥45-Gy isodose lines). RESULTS: Forty-one patients were identified with 121 sites of recurrence (median 2 sites; interquartile range [IQR], 1-4). The median prostate-specific antigen level at CholPET was 3.1 (IQR, 1.9-5.6) ng/mL. Median interval from RT to biochemical failure was 24 (IQR, 10-46) months, with recurrence identified on CholPET at a median of 15 (IQR, 7-28) months from biochemical failure. Histologic confirmation of recurrence was obtained in 20 patients (49%), with the remainder confirmed by treatment response. Five patients (12%) had IF recurrences, 10 patients (24%) had EOF recurrences (median dose 10 Gy; IQR, 5-30 Gy), and 36 patients (88%) had OOF recurrences. Ten patients had combination failures: 6 (15%) EOF/OOF and 4 (10%) IF/OOF. Fifty-seven recurrences (47%) were pelvic nodal sites inferior to the L5-S1 interspace, of which 52 (43%) were within a pelvic RT field. Eighty-one recurrences (67%) were nodal and inferior to the aortic bifurcation. CONCLUSIONS: Using CholPET, we found that the majority of patients evaluated for biochemical failure recurred outside of the postprostatectomy RT field. Furthermore, most recurrence sites were nodal and inferior to the aortic bifurcation. These results provide data that may be useful for examining strategies that include elective lymph node irradiation in postprostatectomy patients.
PURPOSE: To evaluate C-11choline positron emission tomography/computed tomography (CholPET) in staging and determining patterns of recurrence in prostate cancerpatients with rising prostate-specific antigen levels after prostatectomy radiation therapy (RT). METHODS AND MATERIALS: The study includes patients with biochemical failure after postprostatectomy RT who underwent CholPET between 2008 and 2015. Patient and disease characteristics were examined in relation to sites of recurrence. All RT dosimetry records were reviewed, and recurrences were mapped on a representative computed tomography dataset with their relationship relative to the irradiated fossa field as out of field (OOF), edge of field (EOF; recurrence within <45-Gy isodose lines), or in field (IF; recurrence within ≥45-Gy isodose lines). RESULTS: Forty-one patients were identified with 121 sites of recurrence (median 2 sites; interquartile range [IQR], 1-4). The median prostate-specific antigen level at CholPET was 3.1 (IQR, 1.9-5.6) ng/mL. Median interval from RT to biochemical failure was 24 (IQR, 10-46) months, with recurrence identified on CholPET at a median of 15 (IQR, 7-28) months from biochemical failure. Histologic confirmation of recurrence was obtained in 20 patients (49%), with the remainder confirmed by treatment response. Five patients (12%) had IF recurrences, 10 patients (24%) had EOF recurrences (median dose 10 Gy; IQR, 5-30 Gy), and 36 patients (88%) had OOF recurrences. Ten patients had combination failures: 6 (15%) EOF/OOF and 4 (10%) IF/OOF. Fifty-seven recurrences (47%) were pelvic nodal sites inferior to the L5-S1 interspace, of which 52 (43%) were within a pelvic RT field. Eighty-one recurrences (67%) were nodal and inferior to the aortic bifurcation. CONCLUSIONS: Using CholPET, we found that the majority of patients evaluated for biochemical failure recurred outside of the postprostatectomy RT field. Furthermore, most recurrence sites were nodal and inferior to the aortic bifurcation. These results provide data that may be useful for examining strategies that include elective lymph node irradiation in postprostatectomy patients.
Authors: Francesco Greco; Jeffrey A Cadeddu; Inderbir S Gill; Jihad H Kaouk; Mesut Remzi; R Houston Thompson; Fijs W B van Leeuwen; Henk G van der Poel; Paolo Fornara; Jens Rassweiler Journal: Eur Urol Date: 2013-08-07 Impact factor: 20.096
Authors: William P Parker; Brian J Davis; Sean S Park; Kenneth R Olivier; Richard Choo; Mark A Nathan; Val J Lowe; Timothy J Welch; Jaden D Evans; William S Harmsen; Harras B Zaid; Ilya Sobol; Daniel M Moreira; Rimki Haloi; Matthew K Tollefson; Matthew T Gettman; Stephen A Boorjian; Lance A Mynderse; R Jeffrey Karnes; Eugene D Kwon Journal: Eur Urol Date: 2016-09-03 Impact factor: 20.096
Authors: Zachary S Zumsteg; Daniel E Spratt; Paul B Romesser; Xin Pei; Zhigang Zhang; Marisa Kollmeier; Sean McBride; Yoshiya Yamada; Michael J Zelefsky Journal: J Urol Date: 2015-07-10 Impact factor: 7.450
Authors: Jeff M Michalski; Colleen Lawton; Issam El Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard K Valicenti; Anthony L Zietman; Walter R Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard Journal: Int J Radiat Oncol Biol Phys Date: 2009-04-23 Impact factor: 7.038
Authors: Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack Journal: J Clin Oncol Date: 2007-05-20 Impact factor: 44.544
Authors: Piyush K Agarwal; Natalia Sadetsky; Badrinath R Konety; Martin I Resnick; Peter R Carroll Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Jaden D Evans; Lindsay K Morris; Henan Zhang; Siyu Cao; Xin Liu; Kristin C Mara; Bradley J Stish; Brian J Davis; Aaron S Mansfield; Roxana S Dronca; Matthew J Iott; Eugene D Kwon; Robert L Foote; Kenneth R Olivier; Haidong Dong; Sean S Park Journal: Int J Radiat Oncol Biol Phys Date: 2018-09-08 Impact factor: 7.038
Authors: Changhoon Song; Sang Jun Byun; Young Seok Kim; Hanjong Ahn; Seok-Soo Byun; Choung-Soo Kim; Sang Eun Lee; Jae-Sung Kim Journal: PLoS One Date: 2019-04-11 Impact factor: 3.240
Authors: Brian T Welch; Ann T Packard; Thomas D Atwell; Geoffrey B Johnson; Val J Lowe; Robert Jeffrey Karnes; Lance A Mynderse; Tina M Gunderson; Sean S Park; Bradley J Stish; Jaden D Evans; Eugene D Kwon; Brian J Davis; Mark A Nathan Journal: Adv Radiat Oncol Date: 2018-09-05
Authors: Krishan R Jethwa; Christopher D Hellekson; Jaden D Evans; William S Harmsen; Tyler J Wilhite; Thomas J Whitaker; Sean S Park; C Richard Choo; Bradley J Stish; Kenneth R Olivier; Rimki Haloi; Val J Lowe; Brian T Welch; J Fernando Quevedo; Lance A Mynderse; R Jeffrey Karnes; Eugene D Kwon; Brian J Davis Journal: Adv Radiat Oncol Date: 2019-07-04